Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by Benedict16thon Oct 16, 2020 9:23pm
64 Views
Post# 31733316

RE:RE:RE:RE:RE:RE:RE:RE:RE:LATAM'S moat

RE:RE:RE:RE:RE:RE:RE:RE:RE:LATAM'S moatSplitting hairs 28% to 30%? It  is a capital loss, in essence GBT is worth 29% less. Is this the genius action of an investment guru after six Year of waiting and billion dollars in cash? GGT may become if it is not already the Achille’s heal of this proven failed GUD MNGT team. They are becoming the joke of the TSX. Only the oil and gas industry did as bad as GUD. But that too was not the fault of the CEO but more so of geopolitics circumstances. Six Year later and a billion Dollar in cash and a genius team …. Yet they could not find a single good large deal M&A. The sellers of GBT got a hell of good deal though and they are laughing al the way to the bank. Such speak volume of this MNGT. How dare anyone continues brags how good they are. Where is the good news and positive facts about GBT. Come on show us? Oh yes they are keeping up their sleeves. Not even a two-year-old would continue to believe it.   
Meir you were the correct Oracle but us dumb Canadian did not listen to you. I wish I did. Sory we need you back. 
Bullboard Posts